WebCast - Jose “Pepe” Alvarez, Jr., M.D. Memorial Lecture on Vascular Disease: Critical Limb Ischemia Prevention and Control: The Road Ahead
One year after diagnosis of critical limb ischemia (CLI), 25% of patients have died, 30% are alive with amputations, 20% have ongoing symptoms and 25% have symptoms resolved. In managing CLI, the goals are pain relief and the restoration of skin integrity and function. With an estimated yearly incidence of 500 to 1000 new cases per million, CLI poses a substantial burden on patients, healthcare providers, and resources. Dr. Alan Hirsch will assess current challenges in the management of CLI, as well as discuss opportunities to prevent other major complications that could impact patient care.
Cardiologists, Vascular Surgeons, Interventional Radiologists, Interventional Cardiologists, General Surgeons, Podiatrists, Primary Care Physicians, Emergency Medicine Physicians, General Internists, Nurses, Pharmacists, Respiratory Therapists and other interested specialists.
- Assess the diverse mechanisms that underpin the development of critical limb ischemia (CLI), and associated challenges in measuring syndrome incidence and prevalence.
- Identify public health resources used to effectively prevent other major ischemic syndromes (AMI and stroke).
- Distinguish the role of physicians, health professional societies, and public health agencies in achieving "CLI prevention and control."
Pre registration is required. Please log in to register.
Michael R. Jaff, D.O.
President, Newton-Wellesley Hospital
Professor of Medicine, Harvard Medical School
Michael Jaff, D.O. has indicated he is a consultant for Micell and Phylips-Volcano, he is a stock shareholder for Embolitech, PQ Bypass, Vascular Therapies, non-compensated consultant for Abbott Vascular, Boston Scientific, Cordis, Medtronic, and is a board member of VIVA Physicians. His discussion will include off-label or unapproved product usage in their presentations or discussions.
Conference Directors and Planning Committee
James Benenati, M.D. has indicated that he is a consultant for W.L. Gore, Cook and Penumbra. He also has royalties with Penumbra.
Barry T. Katzen, M.D. has indicated that he is a consultant for Boston Scientific, Philips Medical and W.L. Gore.
Others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Non-faculty contributors and other individuals involved in the planning, development, review and editing of the symposium content have indicated neither they nor their spouses/partners have relevant financial relationships.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.